FDA 483 - Vitalant - December 17, 2021

An FDA inspection of Vitalant, a blood bank in Granite Bay, CA, revealed a significant deficiency in record-keeping practices. The firm failed to adequately document donor travel and residence history during screening for malaria risk factors. This lapse in detailed record-keeping could compromise the complete history of work performed to ensure blood product safety.